Obligations in a global health emergency - Authors’ reply

Lancet 398 (10316):2072 (2021)
  Copy   BIBTEX

Abstract

In response to commentators, we argue that whether waiving patent rights will meaningfully improve access to COVID-19 vaccines for low income and middle-income countries (LMICs), particularly in the short term, is an empirical matter. We also reject preferentially allocating vaccines to countries that hosted trials because doing so unethically favours those with research infrastructure, rather than those facing the worst burdens from COVID-19.

Author Profiles

Govind Persad
University of Denver
Kok-Chor Tan
University of Pennsylvania
Lisa Maria Herzog
University of Groningen
2 more

Analytics

Added to PP
2022-02-24

Downloads
175 (#71,016)

6 months
61 (#62,395)

Historical graph of downloads since first upload
This graph includes both downloads from PhilArchive and clicks on external links on PhilPapers.
How can I increase my downloads?